Transdermal Glyceryl Trinitrate [Nitroglycerin] . News and reviews Glyceryl trinitrate transdermal. Pento, J.T.: Drugs of Today 19: 217

(1983) The future of pharmacotherapeutics; trends in drugs, dosage forms and

drug delivery. Banker, G.S. et al. : Pharmacy International 4: 12 (1983)

Cutaneous administration of nitroglycerin: a review. Olivari, M.-T. and Cohn, J .N.: Pharmacotherapy 3: 149 (1983)

Logics of transdermal controlled drug administration. Chien, Y.W.: Drug Development and Industrial Pharmacy 9: 497 (1983)

Development of transdermal therapeutic systems. Shaw, J.: Drug Development and Industrial Pharmacy 9: 579 (1983)

Polymer matrix considerations for transdermal devices. Keith, A.D.: Drug Development and Industrial Pharmacy 9: 605 (1983)

Transderm-Nitro controlled delivery of nitroglycerin via the transdermal route. Good, W.R.: Drug Development and Industrial Pharmacy 9: 647 (1983)

Transdermal delivery of prodrugs. Higuchi, W.1. et al.: Drug Development and Industrial Pharmacy 9: 691 (1983)

Regulatory considerations in transdermal controlled medication. Cabana, B.E.: Drug Development and Industrial Pharmacy 9: 707 (1983)

Azone: A new non-toxic enhancer of cutaneous penetration. Stoughton, R.B. and McClure, W.O.: Drug Development and Industrial Pharmacy 9: 725 (1983)

The brief saga of transdermal nitroglycerin discs: Paradise lost? Abrams, J.: American Journal of Cardiology 54: 220 (1984)

Nitroglycerin patches. Medical leiter 26: 59 (1984)

Pharmacology Hemodynamic and humoral response to transdermal nitroglycerin in

congestive heart failure . Olivari, M.T. et al.: Clinical Research 30: 548A (1982)

Nitroglycerin in a new transdermal therapeutic system: haemodynamic effects in heart failure. Sharpe, D.N. and Coxon, R.: Australian and New Zealand Journal of Medicine 12: 322 (1982)

Human pharmacological studies of a new transdermal system containing nitroglycerin. Muller, P. et al.: European Journal of Clinical Pharmacology 22: 473 (1982)

Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system. Karim, A.: Aniology 34: II (1983)

Transdermal absorption: A unique opportunity for constant delivery of nitroglycerin. Karim, A.: Drug Development and Industrial Pharmacy 9: 671 (1983)

Comparative controlled Skin Permeation of Nitroglycerin from marketed transdermal delivery systems. Chien, Y.W.; et al.: Journal of Pharmaceutical Sciences 72: 968 (1983)

A study of the effect of glyceryl trinitrate (GTN) on systolic time­intervals using the Searle microsealed drug delivery system. Hamer, J. el at.: British Journal of Clinical Pharmacology 15: 599P (1983)

Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment. Taylor, S.H.: Lancet 2: 97 (1984)

Transdermal systems in principle and practice. Holdford, N.H.G. and Paton, D.M.: New Ethicals 21 : 13 (1984)

Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment. Curry, S.H. et al .: Lancet I: 1297 (1984)

Angina - Transdermaltreatment. New Zealand Pharmacy 4: 50 (1984)

Therapeutic use Comparison of transdermal nitroglycerin products. Schwinghammer,

T.L. and Romano, MJ.: American Journal of Hospital Pharmacy 39: 1145 (1982)

Treatment of patients with angina pectoris in general practice with a new transdermal therapeutic system containing nitroglycerin. Garnier, B. et al.: Schweizerische Rundschau fUr Medizin Praxis 71: 511 (1982)

Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectoris. Georgopoulos, A.J. et

0156-2703/ 84/0825-0019/0$01.00/0 ® ADIS Press

al.: European Journal of Clinical Pharmacology 22: 481 (1982)

The treatment of angina pectoris with a nitroglycerin patch. Letzel, H. et al.: Therapie-Woche 32: 6053-6062 (1982)

Transdermal delivery systems for nitroglycerin. Medical leiter 24: 35 (1982)

Evaluation of the efficacy and the length of action of a new preparation of slow-release nitroglycerin for percutaneous absorption (Nitro-Dur, Sigma-Tau) in angina pectoris caused by exercise. Schiavoni, G. et al.: International Journal of Clinical Pharmacology Research 2: 15 (1983)

Clinical use of transdermal delivery devices with nitroglycerin: Thompson, R.H.: Angiology 34: 23 (1983)

Clinical use of transdermal delivery devices with nitroglycerin. Thompson, R.: Circulation 68: 111-407 (1983)

Continuous transdermal nitroglycerin administration in the treatment of chronic angina pectoris. Crean, P.A. et al.: Circulation 68: 111-405 (1983)

Antianginal effects of nitroglycerin patches do not last twenty-four hours. Reichek, N. et al.: Circulation 68: 111-407 (1983)

Dosage from transdermal nitroglycerin pads. Correspondence. Karim, A. et al.: 10urnal of the American Medical Association 250: 3162 (1983)

Transdermal nitroglycerin patches. Therapaeia 5: 9 (1983) Long-term nitrate therapy - New generation of transdermal systems.

Mahr, H.: Herz-Kreislauf 15: 302 (\ 983)

Microsealed drug delivery - nitroglycerin (MDD-NG). Friedlander, D.H. and Nairn, P.L.: New Zealand Medical Journal 96: 221 (1983)

Efficacy of transdermal nitroglycerin patches in patients with angina pectoris. Hollenberg, M. and Go, M.: Cardiovascular Reviews and Reports 5: 328 (1984)

Potential medication error with transderrnal nitroglycerin. Burris, J.F.: Drug Intelligence and Clinical Pharmacy 18: 480 (1984)

Transdermal nitroglycerin in the treatment of Raynaud's phenomenon: Analysis of digital blood pressure changes after cold provocation. Sovijarvi, A.R.A. et al.: Current Therapeutic Research 35: 832 (1984)

Nitroglycerin in a transdermal therapeutic system in chronic heart failure. Sharpe, D.N. and Coxon, R.: Journal of Cardiovascular Pharmacology 6: 76: (1984)

Efficacy of transdermal nitroglycerin on haemodynamics and exercise tolerance in patients with coronary heart disease. Osterspey, A. et al .: Deutsche Medizinische Wochenschrifl. 109: 714 (1984)

Nitradisc in unstable angina pectoris and continuing chest pain after acute myocardial infarction. Correspondence. Przybojewski, J .Z.: South African Medical Journal 65: 192 (1984)

Post-Marketing Surveillance of the Transderm-Nitro Patch in General Practice. Bridgman, K.M. et al.: Journal of International Medical Research 12: 40 (1984)

Long-Acting Nitrates: Relative Utility of Nitrogen Patches. Reichek, N.: American Journal of Medicine 76: 63 (1984)

Antianginal Effects of Nitroglycerin Patches. Reicheck, N. et al.: American Journal of Cardiology 54: 1(1984)

Acute titration with transderm-nitro in angina pectoris. Nitroglycerine treatment revisited. Mahapatra, R.K. et al.: Clinical Research 32: 187A (1984)

Transdermal nitroglycerin in angina pectoris. Parker, J.O. and Fung, H-L.: Clinical Research 32: 196A (1984)

INPHARMA® 25 Aug 1984 19